Sylva Janovska
Overview
Explore the profile of Sylva Janovska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pudelka L, Sleha R, Janovska S, Radochova V, Bostik P
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065691
An increasing resistance of microbes to antibiotics, the emergence of multidrug-resistant and extremely resistant strains, and the long time needed to develop new antibiotics are driving the search for additional...
2.
Priester P, Fajfr M, Molnarova V, Sleha R, Janovska S, Bostik P, et al.
Vaccines (Basel)
. 2024 Mar;
12(3).
PMID: 38543933
Aside from the general population, the COVID-19 pandemic has also affected a group of patients in palliative oncology care. In this study, long-term immune responses against SARS-CoV-2 after vaccination were...
3.
Slovakova M, Janovska S, Sleha R, Radochova V, Hatala A, Mannova N, et al.
J Microbiol Biotechnol
. 2024 Feb;
34(3):663-672.
PMID: 38303144
The use of nanoparticles as a delivery system for a specific antigen could solve many limitations of mucosal vaccine applications, such as low immunogenicity, or antigen protection and stabilization. In...
4.
Fajfr M, Pajer P, Ruzek D, Sleha R, Janovska S, Bohonek M, et al.
Sci Rep
. 2024 Jan;
14(1):1421.
PMID: 38228735
Diagnosis of SARS-CoV-2 virus is mainly based on direct detection. Determination of specific antibodies has been used mostly for epidemiological reasons. However, select immunoassays showed good correlation to plaque reduction...
5.
Fajfr M, Sleha R, Janovska S, Koblizek V, Skala M, Plisek S, et al.
Viruses
. 2022 Mar;
14(3).
PMID: 35336932
Background: The diagnosis of SARS-CoV-2 is almost exclusively performed by PCR or antigen detection. The detection of specific antibodies has not yet been considered in official diagnostic guidelines as major...
6.
Sleha R, Radochova V, Malis J, Mikyska A, Houska M, Krofta K, et al.
Antibiotics (Basel)
. 2021 Jul;
10(6).
PMID: 34204644
() is an important causative agent of wound infections with increasing incidence in the past decades. Specifically, the emergence of methicillin-resistant (MRSA) causes serious problems, especially in nosocomial infections. Therefore,...
7.
Sleha R, Radochova V, Mikyska A, Houska M, Bolehovska R, Janovska S, et al.
Antibiotics (Basel)
. 2021 Apr;
10(4).
PMID: 33917416
() is an important causative pathogen of nosocomial gastrointestinal infections in humans with an increasing incidence, morbidity, and mortality. The available treatment options against this pathogen are limited. The standard...
8.
Krocova E, Neradova S, Kupcik R, Janovska S, Bilkova Z, Heidingsfeld O
FEMS Yeast Res
. 2018 Oct;
19(1).
PMID: 30304493
Most of the phosphatases of human fungal pathogens Candida albicans and C. parapsilosis have never been experimentally characterised, although dephosphorylation reactions are central to many biological processes. PHO15 genes of...
9.
Vavrova J, Janovska S, Rezacova M, Hernychova L, Ticha Z, Vokurkova D, et al.
Mol Cell Biochem
. 2007 Apr;
303(1-2):53-61.
PMID: 17426928
The effect of valproic acid (VA) on protein expression in human T-lymphocytic leukemia cells MOLT-4 was studied. VA is an inhibitor of histonedeacetylases and has a potential use as antitumor...
10.
Janovska S, Pavkova I, Hubalek M, Lenco J, Macela A, Stulik J
Immunol Lett
. 2007 Jan;
108(2):151-9.
PMID: 17241671
Francisella tularensis is a Gram-negative, facultative intracellular bacterium causing disease in many mammalian species. The low infectious dose of F. tularensis and the ease of air-borne transmission are the main...